CONCERV Studie
- Conditions
- Stage IB1 cervical cancer,
- Registration Number
- NL-OMON24972
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Histologically confirmed squamous cell carcinoma of the cervix (any grade) or Histologically confirmed grade 1 or 2 adenocarcinoma of the cervix
2. FIGO stage IA2 or IB1 disease
Exclusion Criteria
1. Clear cell, neuroendocrine, adenosquamous, serous carcinoma or other high-risk histologies
2. Grade 3 adenocarcinoma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immediate Failure Rate [ Time Frame: 5 Years ]<br /><br>The immediate failure rate is defined as residual disease in the simple hysterectomy specimen.
- Secondary Outcome Measures
Name Time Method Recurrence rate after two years